Compare Howmet Aerospace Inc (HWM) vs BIO-TECHNE Corp (TECH) Price & Performance

Howmet Aerospace (HWM) trades at $222.70, down 3.84% amid bearish technical signals, though fundamentals remain strong with consistent earnings beats and robust profitability. The stock shows solid revenue growth from $8.25B in 2025 to $9.1B projected for 2026, with net margins improving to 20.52%. Recent news highlights defense and aerospace demand drivers, while analyst consensus remains overwhelmingly bullish with an average price target of $328.10 representing 47% upside potential.

HWM presents a compelling growth story with strong fundamentals and analyst support, though technical weakness and high valuation multiples warrant caution. The primary investment thesis centers on continued aerospace sector strength and execution on growth initiatives, while risks include valuation compression and sector-specific headwinds. Current levels may offer entry points for long-term investors despite near-term technical pressure.

TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.

Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.